ITEMS IN AFP WITH KEYWORD:
In patients with a significant (greater than 50 pack-year) history of smoking, yearly screening for lung cancer using low-dose computed tomography (CT) will extend their lives. A significant proportion of screened patients will have a false-positive finding or a finding not related to lung cancer.
Case study: A 55-year-old woman presents for a routine well-woman examination. She states that she is worried about ovarian cancer because one of her friends was recently diagnosed. She has no family history of breast, ovarian, or colon cancer.
May 15, 2013 Issue
Screening for Ovarian Cancer: Reaffirmation Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends against screening for ovarian cancer in women.
Mar 15, 2013 Issue
Screening for Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection [FPIN's Clinical Inquiries]
There is no evidence that it is beneficial to screen for hepatocellular carcinoma in symptomatic patients with HCV.
Case Study: A 61-year-old black man presents for a routine checkup. He has hypertension and diabetes mellitus that are well controlled with medication. During the visit, he tells you that a friend advised him to get a prostate-specific antigen (PSA) test to screen for prostate cancer, and he would like to pursue testing.
Feb 15, 2013 Issue
Screening for Prostate Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends against prostate-specific antigen (PSA)-based screening for prostate cancer.
Dec 15, 2012 Issue
ACP Releases Best Practice Advice on Colorectal Cancer Screening [Practice Guidelines]
The American College of Physicians (ACP) recently reviewed guidelines on colorectal cancer screening available from the American Cancer Society/U.S. Multi-Society Task Force on Colorectal Cancer/American College of Radiology, Institute for Clinical Systems Improvement, U.S. Preventive Services Task ...
The American Cancer Society (ACS), the American Society for Colposcopy and Cervical Pathology (ASCCP), and the American Society for Clinical Pathology (ASCP) recently published updated recommendations for the early detection of cervical cancer. The guidelines are based on a systematic evidence review.
Sep 15, 2012 Issue
Screening for Cervical Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends screening for cervical cancer in women 21 to 65 years of age with cytology (Papanicolaou [Pap] smear) every three years or, for women 30 to 65 years of age who want to lengthen the screening interval, screening with a combination of cytolog...
Case study: J.K., a 45-year-old woman, presents to your office for a routine well-woman examination. She has been married for 20 years, and there is nothing remarkable in her medical history, including no previous abnormal Papanicolaou (Pap) smears.